Descobertas no Holter de 24 horas (H24H) e no Teste de Mesa Inclinada (TMI) de pacientes em situação pós-COVID-19
Barra lateral de artigos
Como Citar
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
##plugins.themes.bootstrap3.displayStats.downloads##
Societal impact
Conteúdo do artigo principal
Resumo
Objetivo: descrever os achados no Holter de 24 horas (H24H) e no Teste de Mesa Inclinada (TMI) em pacientes em situação pós-COVID-19 (SPC) e explorar sua associação
com sintomas.
Metodologia: estudo descritivo transversal no qual foram incluídos 83 pacientes em SPC com H24H ou PMB. Por meio de inquérito telefônico foram obtidas variáveis demográficas, sintomas e comorbidades; H24H e PMB foram revisados por um cardiologista e um eletrofisiologista. Foram excluídos pacientes com histórico de arritmias, disautonomia e portadores de marca-passo.
Resultados: 57,6% dos pacientes eram mulheres e a idade média foi de 48,5 anos. As palpitações foram o sintoma mais frequente (65,1%). 74,7% foram tratados em casa durante a infecção aguda. Em média, decorreram 8,4 meses entre o diagnóstico de COVID-19 e o H24H ou PMB. Dos 64 H24H realizados, pelo menos 34 tiveram achado em pacientes que apresentavam com maior frequência fadiga e dispneia, o achado mais comum foi taquicardia sinusal em repouso ou com mínimo esforço (34%). Em 27 PMB os achados mais repetidos foram síncope ou pré-síncope misto vasovagal (48%) e vasodepressor (22%), tontura/síncope foi o sintoma mais comum em comparação com aqueles que não apresentaram esses achados.
Conclusões: No SPC as palpitações foram o sintoma mais frequente, os achados mais comuns no H24H foram: ter exame normal e taquicardia sinusal em repouso ou com mínimo esforço. No PBM houve repetição de síncope ou pré-síncope vasovagal misto.
Detalhes do artigo
Referências
Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 Infection: Illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251-2.
Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157-72.
Daugherty SE, Guo Y, Heath K, Dasmariñas MC, Jubilo KG, Samranvedhya J, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373:n1098.
Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-5.
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. The Lancet. 2021;397(10270):220-32.
del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA. 2020;324(17):1723-4.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-9.
Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498.
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427-520.
Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-948.
Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis. JAMA Intern Med. 2023;e230750.
Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.
Monaghan A, Jennings G, Xue F, Byrne L, Duggan E, Romero-Ortuno R. Orthostatic intolerance in adults reporting long COVID symptoms was not associated with postural orthostatic tachycardia syndrome. Front Physiol. 2022;13:833650.
Ingul CB, Grimsmo J, Mecinaj A, Trebinjac D, Berger Nossen M, Andrup S, et al. Cardiac dysfunction, and arrhythmias 3 months after hospitalization for COVID‐19. J Am Heart Assoc. 2022;11(3):e023473.
Radin JM, Quer G, Ramos E, Baca-Motes K, Gadaleta M, Topol EJ, et al. Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection. JAMA Netw Open. 2021;4(7):e2115959.
Aranyó J, Bazan V, Lladós G, Dominguez MJ, Bisbal F, Massanella M, et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep. 2022;12(1):298.
Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: A case series of 20 patients. Immunol Res. 2021;69(2):205-11.
Wang W, Wang CY, Wang SI, Wei JCC. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53:101619.
Jamal SM, Landers DB, Hollenberg SM, Turi ZG, Glotzer TV, Tancredi J, et al. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J Am Coll Cardiol. 2022;79(23):2325-30.
Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in «long COVID»: rationale, physiology, and management strategies. Clin Med Lond. 2021;21(1):e63-7.
Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020;95(8):e1060-70.
Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses, and the cardiovascular system: Acute and long-term implications. Eur Heart J. 2020;41(19):1798-800.
Hernández-Mercado MA, Hernández-Tirado V, Tirado-García LA, Rivera-Figueroa J, Morales-Bernal NE. Taquicardia sinusal post-COVID-19: patogenia, identificación y estratificación temprana. Rev Colomb Cardiol. 2022;29(4):485-94.